([a]D, NMR, mass) with the natural one ([a]1D8 +179 (c 0.2,
CHCl3)). Therefore, the absolute configuration of psycho-
trimine was established, as shown in formula 1.
Synthetic (+)-psychotrimine was evaluated for its cytotoxic
activity against three tumor cell lines, A549, HT29, and
HTC116. As a result, 1 showed moderate cytotoxicity to only
HT-29 (human colon adenocarcinoma grade II cell line;
IC50 = 3.00 mg mLꢂ1).
In conclusion, we have achieved the first asymmetric total
synthesis of cytotoxic psychotrimine (1) via an asymmetric
Ireland–Claisen rearrangement to construct a chiral quaternary
carbon center, which enabled us to determine the absolute
configuration of the natural product.
This work was supported by a Grant-in-Aid for Scientific
Research from the Japan Society for the Promotion of Science.
Notes and references
1 For recent reviews, see: (a) U. Anthoni, C. Christophersen and
P. H. Nielsen, in Alkaloids: Chemical and Biological Perspectives,
ed. S. W. Pelletier, Pergamon, New York, 1999, vol. 13,
pp. 163–236; (b) A. Steven and L. E. Overman, Angew. Chem.,
Int. Ed., 2007, 46, 5488–5508.
2 For recent reports of the synthesis of pyrrolidinoindoline alkaloids,
see: (a) A. B. Dounay and L. E. Overman, Chem. Rev., 2003, 103,
2945–2964; (b) J. J. Kodanko and L. E. Overman, Angew. Chem.,
Int. Ed., 2003, 42, 2528–2531; (c) J. F. Austin, S.-G. Kim,
C. J. Sinz, W.-J. Xiao and D. W. C. MacMillan, Proc. Natl. Acad.
Sci. U. S. A., 2004, 101, 5482–5487; (d) C. Menozzi, P. I. Dalko
Scheme 4
nitroethylene–InBr3 to afford 21, (3) reduction of the nitro
group with Fe–AcOH, followed by protection of the resulting
primary amine with nitrobenzenesulfonamide (Ns-amide), (4)
N-methylation, (5) removal of the Boc group to yield 24, (6)
coupling with tryptamine derivative 25 by copper-mediated
intermolecular amination to give trimeric product 26, and (7)
removal of the Ns group to furnish psychotrimine in 75%
yield. Synthetic 1 ([a]D24 +221 (c 0.3, CHCl3)) with 3aS and
8aR stereochemistry was completely identical in all respects
and
J.
Cossy,
Chem.
Commun.,
2006,
4638–4640;
(e) M. Movassaghi and M. A. Schmidt, Angew. Chem., Int. Ed.,
2007, 46, 3725–3728; (f) J. Kim, J. A. Ashenhurst and
M. Movassaghi, Science, 2009, 324, 238–241.
3 (a) T. A. Amador, L. Verrota, D. S. Nunes and E. Elisabetsky,
Planta Med., 2000, 66, 770–772; (b) T. A. Amador, L. Verrota,
D. S. Nunes and E. Elisabetsky, Phytomedicine, 2001, 8, 202–206;
(c) L. Verotta, F. Orsini, M. Sbacchi, M. A. Scheildler,
T. A. Amador and E. Elisabetsky, Bioorg. Med. Chem., 2002, 10,
2133–2142; (d) J. J. Kodanko, S. Hiebert, E. A. Peterson, L. Sung,
L. E. Overman, V. M. Linck, G. C. Goerck, T. A. Amador,
M. B. Leal and E. Elisabetsky, J. Org. Chem., 2007, 72, 7909–7914.
4 (a) H. Takayama, H. Ishikawa, M. Kurihara, M. Kitajima,
N. Aimi, D. Ponglux, F. Koyama, K. Matsumoto, T. Moriyama,
L. T. Yamamoto, K. Watanabe, T. Murayama and S. Horie,
J. Med. Chem., 2002, 45, 1949–1956; (b) K. Matsumoto,
S. Horie, H. Ishikawa, H. Takayama, N. Aimi, D. Ponglux and
K. Watanabe, Life Sci., 2004, 74, 2143–2155; (c) H. Takayama,
K. Misawa, N. Okada, H. Ishikawa, M. Kitajima, Y. Hatori,
T. Murayama, S. Wongseripipatana, K. Tashima, K. Matsumoto
and S. Horie, Org. Lett., 2006, 8, 5705–5708 and references therein.
5 H. Takayama, I. Mori, M. Kitajima, N. Aimi and N. H. Lajis, Org.
Lett., 2004, 6, 2945–2948.
6 Y. Matsuda, M. Kitajima and H. Takayama, Org. Lett., 2008, 10,
125–128.
7 T. Newhouse and P. S. Baran, J. Am. Chem. Soc., 2008, 130,
10886–10887.
8 (a) A. M. M. Castro, Chem. Rev., 2004, 104, 2939–3002;
(b) Y. Chai, S. Hong, H. A. Lindsay, C. McFarland and
M. C. McIntosh, Tetrahedron, 2002, 58, 2905–2928;
(c) D. A. Clark, A. A. Kulkarni, K. Kalbarcsyk, B. Schertzer
and S. T. Diver, J. Am. Chem. Soc., 2006, 128, 15632–15636.
9 (a) O. V. Singh and H. Han, Org. Lett., 2007, 9, 4801–4804;
(b) S. Kusuda, Y. Ueno and T. Toru, Tetrahedron, 1994, 50,
1045–1062.
10 T. Mukaiyama and S. Funasaka, Chem. Lett., 2007, 36, 326–327.
Scheme 5
ꢁc
This journal is The Royal Society of Chemistry 2010
Chem. Commun., 2010, 46, 2501–2503 | 2503